Dexco Expects Non-Recurring Write-Offs to Cut 3Q26 EBITDA by BRL 190 Million
Dexco expects non-recurring write-offs to reduce 3Q26 EBITDA by BRL 190 million.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.